|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenues | |||||
| Cost of sales | |||||
| Gross profit | |||||
| Wage and salary expense | |||||
| Professional fees | |||||
| Accounting and legal expense | |||||
| Technology expense | |||||
| General and administrative | |||||
| Research and development | |||||
| Impairment loss | |||||
| Total operating expenses | |||||
| Operating loss | |||||
| Non-operating income (expense): | |||||
| Change in fair value of warrant liability | |||||
| Change in fair value of derivative liability | |||||
| Impairment of investment | |||||
| Loss on conversion of note payable | |||||
| Loss on disposition of subsidiaries | |||||
| Interest income | |||||
| Goodwill impairment | |||||
| Operating lease right-of-use assets | |||||
| Other income | |||||
| Interest expense | |||||
| Total non-operating expense | |||||
| Net loss from continuing operations | |||||
| Benefit / (provision) for income taxes | |||||
| Net loss from continuing operations, net of tax | |||||
| Net income from discontinued operations, net of tax | |||||
| Net Loss | |||||
| Net (loss) income | |||||
| Net loss per common share from continuing operations | |||||
| Basic | |||||
| Diluted | |||||
| Net income per common share from discontinued operations | |||||
| Basic | |||||
| Diluted | |||||
| Net (loss) income per common share | |||||
| Basic | |||||
| Diluted | |||||
| Weighted average common shares outstanding | |||||
| Basic | |||||
| Diluted | |||||
Loading...